0.010054 0.005805 0.000000 0.000000 0.011610 0.000000 0.000000 0.000000 0.023759 0.00000 0.00000 0.00000 Griffith, D.L. Scott, D.L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 6 90.00 90.00 120.00 99.460 99.460 42.090 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 93 878 883 10.1073/pnas.93.2.878 8570652 Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily. 1996 UK J.Mol.Biol. JMOBAK 0070 0022-2836 244 657 Crystallization and Preliminary Crystallographic Data of Recombinant Human Osteogenic Protein-1 (Hop-1) 1994 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 IMAGE PLATE 1993-11-30 RIGAKU M x-ray 1 1.5418 1.0 1.5418 15699.730 BONE MORPHOGENETIC PROTEIN-7 1 man polymer OSTEOGENIC PROTEIN-1, HOP-1, BMP-7 no no STGSKQRSQNRSKTPKNQEALRMANVAENSSSDQRQACKKHELYVSFRDLGWQDWIIAPEGYAAYYCEGECAFPLNSYMN ATNHAIVQTLVHFINPETVPKPCCAPTQLNAISVLYFDDSSNVILKKYRNMVVRACGCH STGSKQRSQNRSKTPKNQEALRMANVAENSSSDQRQACKKHELYVSFRDLGWQDWIIAPEGYAAYYCEGECAFPLNSYMN ATNHAIVQTLVHFINPETVPKPCCAPTQLNAISVLYFDDSSNVILKKYRNMVVRACGCH A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Chinese hamster Cricetulus sample REFERENCE, T.K. SAMPATH, ET AL. (1992) J. BIOL. CHEM. 267, 20452-20362 HOP-1 CDNA 9606 OVARY Homo sapiens HOP-1 CDNA 10029 Cricetulus griseus 3.83 60. repository Initial release Version format compliance Derived calculations Version format compliance 1 0 1997-07-23 1 1 2008-03-24 1 2 2011-07-13 Y 1995-12-14 REL n 1 1 A n 2 2 A n 3 3 A n 4 4 A n 5 5 A n 6 6 A n 7 7 A n 8 8 A n 9 9 A n 10 10 A n 11 11 A n 12 12 A n 13 13 A n 14 14 A n 15 15 A n 16 16 A n 17 17 A n 18 18 A n 19 19 A n 20 20 A n 21 21 A n 22 22 A n 23 23 A n 24 24 A n 25 25 A n 26 26 A n 27 27 A n 28 28 A n 29 29 A n 30 30 A n 31 31 A n 32 32 A n 33 33 A n 34 34 A n 35 35 A GLN 36 n 36 GLN 36 A ALA 37 n 37 ALA 37 A CYS 38 n 38 CYS 38 A LYS 39 n 39 LYS 39 A LYS 40 n 40 LYS 40 A HIS 41 n 41 HIS 41 A GLU 42 n 42 GLU 42 A LEU 43 n 43 LEU 43 A TYR 44 n 44 TYR 44 A VAL 45 n 45 VAL 45 A SER 46 n 46 SER 46 A PHE 47 n 47 PHE 47 A ARG 48 n 48 ARG 48 A ASP 49 n 49 ASP 49 A LEU 50 n 50 LEU 50 A GLY 51 n 51 GLY 51 A TRP 52 n 52 TRP 52 A GLN 53 n 53 GLN 53 A ASP 54 n 54 ASP 54 A TRP 55 n 55 TRP 55 A ILE 56 n 56 ILE 56 A ILE 57 n 57 ILE 57 A ALA 58 n 58 ALA 58 A PRO 59 n 59 PRO 59 A GLU 60 n 60 GLU 60 A GLY 61 n 61 GLY 61 A TYR 62 n 62 TYR 62 A ALA 63 n 63 ALA 63 A ALA 64 n 64 ALA 64 A TYR 65 n 65 TYR 65 A TYR 66 n 66 TYR 66 A CYS 67 n 67 CYS 67 A GLU 68 n 68 GLU 68 A GLY 69 n 69 GLY 69 A GLU 70 n 70 GLU 70 A CYS 71 n 71 CYS 71 A ALA 72 n 72 ALA 72 A PHE 73 n 73 PHE 73 A PRO 74 n 74 PRO 74 A LEU 75 n 75 LEU 75 A ASN 76 n 76 ASN 76 A SER 77 n 77 SER 77 A TYR 78 n 78 TYR 78 A MET 79 n 79 MET 79 A ASN 80 n 80 ASN 80 A ALA 81 n 81 ALA 81 A THR 82 n 82 THR 82 A ASN 83 n 83 ASN 83 A HIS 84 n 84 HIS 84 A ALA 85 n 85 ALA 85 A ILE 86 n 86 ILE 86 A VAL 87 n 87 VAL 87 A GLN 88 n 88 GLN 88 A THR 89 n 89 THR 89 A LEU 90 n 90 LEU 90 A VAL 91 n 91 VAL 91 A HIS 92 n 92 HIS 92 A PHE 93 n 93 PHE 93 A ILE 94 n 94 ILE 94 A ASN 95 n 95 ASN 95 A PRO 96 n 96 PRO 96 A GLU 97 n 97 GLU 97 A THR 98 n 98 THR 98 A VAL 99 n 99 VAL 99 A PRO 100 n 100 PRO 100 A LYS 101 n 101 LYS 101 A PRO 102 n 102 PRO 102 A CYS 103 n 103 CYS 103 A CYS 104 n 104 CYS 104 A ALA 105 n 105 ALA 105 A PRO 106 n 106 PRO 106 A THR 107 n 107 THR 107 A GLN 108 n 108 GLN 108 A LEU 109 n 109 LEU 109 A ASN 110 n 110 ASN 110 A ALA 111 n 111 ALA 111 A ILE 112 n 112 ILE 112 A SER 113 n 113 SER 113 A VAL 114 n 114 VAL 114 A LEU 115 n 115 LEU 115 A TYR 116 n 116 TYR 116 A PHE 117 n 117 PHE 117 A ASP 118 n 118 ASP 118 A ASP 119 n 119 ASP 119 A SER 120 n 120 SER 120 A SER 121 n 121 SER 121 A ASN 122 n 122 ASN 122 A VAL 123 n 123 VAL 123 A ILE 124 n 124 ILE 124 A LEU 125 n 125 LEU 125 A LYS 126 n 126 LYS 126 A LYS 127 n 127 LYS 127 A TYR 128 n 128 TYR 128 A ARG 129 n 129 ARG 129 A ASN 130 n 130 ASN 130 A MET 131 n 131 MET 131 A VAL 132 n 132 VAL 132 A VAL 133 n 133 VAL 133 A ARG 134 n 134 ARG 134 A ALA 135 n 135 ALA 135 A CYS 136 n 136 CYS 136 A GLY 137 n 137 GLY 137 A CYS 138 n 138 CYS 138 A HIS 139 n 139 HIS 139 A author_and_software_defined_assembly PISA,PQS 2 dimeric 2370 -26 11690 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -0.5000000000 0.8660254038 0.0000000000 0.8660254038 0.5000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 4_555 y,x,-z crystal symmetry operation 0.0000000000 0.0000000000 0.0000000000 A O LYS 39 A O LYS 39 A N GLU 68 A N GLU 68 A O VAL 45 A O VAL 45 A N TYR 62 A N TYR 62 A O ILE 112 A O ILE 112 A N TYR 128 A N TYR 128 A O CYS 103 A O CYS 103 A N HIS 139 A N HIS 139 1 A SER 1 A SER 1 1 Y 1 A THR 2 A THR 2 1 Y 1 A GLY 3 A GLY 3 1 Y 1 A SER 4 A SER 4 1 Y 1 A LYS 5 A LYS 5 1 Y 1 A GLN 6 A GLN 6 1 Y 1 A ARG 7 A ARG 7 1 Y 1 A SER 8 A SER 8 1 Y 1 A GLN 9 A GLN 9 1 Y 1 A ASN 10 A ASN 10 1 Y 1 A ARG 11 A ARG 11 1 Y 1 A SER 12 A SER 12 1 Y 1 A LYS 13 A LYS 13 1 Y 1 A THR 14 A THR 14 1 Y 1 A PRO 15 A PRO 15 1 Y 1 A LYS 16 A LYS 16 1 Y 1 A ASN 17 A ASN 17 1 Y 1 A GLN 18 A GLN 18 1 Y 1 A GLU 19 A GLU 19 1 Y 1 A ALA 20 A ALA 20 1 Y 1 A LEU 21 A LEU 21 1 Y 1 A ARG 22 A ARG 22 1 Y 1 A MET 23 A MET 23 1 Y 1 A ALA 24 A ALA 24 1 Y 1 A ASN 25 A ASN 25 1 Y 1 A VAL 26 A VAL 26 1 Y 1 A ALA 27 A ALA 27 1 Y 1 A GLU 28 A GLU 28 1 Y 1 A ASN 29 A ASN 29 1 Y 1 A SER 30 A SER 30 1 Y 1 A SER 31 A SER 31 1 Y 1 A SER 32 A SER 32 1 Y 1 A ASP 33 A ASP 33 1 Y 1 A GLN 34 A GLN 34 1 Y 1 A ARG 35 A ARG 35 1 Y 1 A GLU 42 12.67 1 A TYR 44 11.12 1 A VAL 45 12.60 1 A ASP 49 17.81 1 A TRP 55 14.50 1 A ILE 56 -13.16 1 A ILE 57 11.66 1 A ALA 58 -11.58 1 A PHE 73 15.50 1 A ALA 85 11.05 1 A VAL 91 12.43 1 A PRO 102 -10.21 1 A LEU 109 -14.68 1 A VAL 123 -10.37 1 A CYS 136 -10.42 1 A ARG 129 0.095 SIDE CHAIN 1 A ARG 134 0.248 SIDE CHAIN 1 A TRP 52 -64.51 19.70 1 A TYR 65 63.72 173.88 1 A TYR 78 -81.65 47.59 1 A MET 79 -154.22 6.04 1 A ASN 80 22.96 96.27 1 A ASN 95 -157.97 78.50 1 A ASP 118 -67.98 -178.51 1 A ASP 119 -52.29 -178.81 1 A SER 120 68.50 -23.63 1 A ASN 130 72.46 43.08 28.48 LOOP REGION (RESIDUES 118 - 122) IS DISORDERED AND MODELED STEREOCHEMICALLY. NOTE THAT RESIDUE 59 IS DESCRIBED AS TRANS IN THE PAPER CITED ON JRNL RECORDS ABOVE BUT THE CURRENT MODEL PRESENTED IN THIS ENTRY HAS RESIDUE 59 AS CIS. 0.308 0.227 2.8 10. 5418 1 2.0 0.25 2.8 10. 0 828 0 0 828 0.008 0.030 0.025 0.050 0.138 0.100 0.045 0.100 0.211 1.00 0.185 1.0 0.250 1.0 0.194 1.0 23.2 30. 25.9 50.0 35.1 50.0 1BMP 5502 2. 0.067 1 2.6 87. data collection R-AXIS SOFTWARE data reduction R-AXIS SOFTWARE model building X-PLOR refinement PROFFT refinement X-PLOR data scaling R-AXIS phasing X-PLOR BONE MORPHOGENETIC PROTEIN-7 BONE MORPHOGENETIC PROTEIN-7 1 N N A HIS 84 A HIS 84 HELX_P A PHE 93 A PHE 93 1 1 10 disulf 2.022 A CYS 38 A SG CYS 38 1_555 A CYS 104 A SG CYS 104 1_555 disulf 2.054 A CYS 67 A SG CYS 67 1_555 A CYS 136 A SG CYS 136 1_555 disulf 2.014 A CYS 71 A SG CYS 71 1_555 A CYS 138 A SG CYS 138 1_555 disulf 1.948 A CYS 103 A SG CYS 103 1_555 A CYS 103 A SG CYS 103 4_555 TRANSFORMING GROWTH FACTOR MORPHOGEN, TRANSFORMING GROWTH FACTOR, CYTOKINE, BONE, CARTILAGE, GLYCOPROTEIN A ALA 58 A ALA 58 1 A PRO 59 A PRO 59 -27.14 A PHE 73 A PHE 73 1 A PRO 74 A PRO 74 20.83 BMP7_HUMAN UNP 1 1 P18075 MHVRSLRAAAPHSFVALWAPLFLLRSALADFSLDNEVHSSFIHRRLRSQERREMQREILSILGLPHRPRPHLQGKHNSAP MFMLDLYNAMAVEEGGGPGGQGFSYPYKAVFSTQGPPLASLQDSHFLTDADMVMSFVNLVEHDKEFFHPRYHHREFRFDL SKIPEGEAVTAAEFRIYKDYIRERFDNETFRISVYQVLQEHLGRESDLFLLDSRTLWASEEGWLVFDITATSNHWVVNPR HNLGLQLSVETLDGQSINPKLAGLIGRHGPQNKQPFMVAFFKATEVHFRSIRSTGSKQRSQNRSKTPKNQEALRMANVAE NSSSDQRQACKKHELYVSFRDLGWQDWIIAPEGYAAYYCEGECAFPLNSYMNATNHAIVQTLVHFINPETVPKPCCAPTQ LNAISVLYFDDSSNVILKKYRNMVVRACGCH 293 431 1BMP 1 139 P18075 A 1 1 139 2 2 2 2 anti-parallel anti-parallel anti-parallel anti-parallel A LYS 39 A LYS 39 A HIS 41 A HIS 41 A TYR 66 A TYR 66 A GLU 68 A GLU 68 A TYR 44 A TYR 44 A SER 46 A SER 46 A GLY 61 A GLY 61 A ALA 63 A ALA 63 A ILE 112 A ILE 112 A PHE 117 A PHE 117 A VAL 123 A VAL 123 A TYR 128 A TYR 128 A CYS 103 A CYS 103 A GLN 108 A GLN 108 A ALA 135 A ALA 135 A HIS 139 A HIS 139 154 P 32 2 1